My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 185

    1.

    Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).

    Bunn PA Jr, Hoffman SJ, Norris D, Golitz LE, Aeling JL.

    Ann Intern Med. 1994 Oct 15;121(8):592-602. Review.PMID: 8085692 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Therapeutic alternatives in cutaneous T-cell lymphoma.

    Holloway KB, Flowers FP, Ramos-Caro FA.

    J Am Acad Dermatol. 1992 Sep;27(3):367-78. Review.PMID: 1383293 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment of cutaneous T cell lymphoma: current status and future directions.

    Apisarnthanarax N, Talpur R, Duvic M.

    Am J Clin Dermatol. 2002;3(3):193-215. Review.PMID: 11978140 [PubMed - indexed for MEDLINE]Related articles

    4.

    State of the art therapy of mycosis fungoides and Sézary syndrome.

    Kemme DJ, Bunn PA Jr.

    Oncology (Williston Park). 1992 Feb;6(2):31-42; discussion 44, 47-8. Review. Erratum in: Oncology (Huntingt) 1992 Aug;6(8):41. PMID: 1532501 [PubMed - indexed for MEDLINE]Related articles

    5.

    Systemic treatment for cutaneous lymphomas.

    Mielke V, Staib G, Sterry W.

    Recent Results Cancer Res. 1995;139:403-8. Review.PMID: 7597307 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Current therapy concepts in cutaneous T-cell lymphomas]

    Nestle FO, Häffner AC, Schmid MH, Dummer R, Burg G.

    Schweiz Med Wochenschr. 1997 Feb 22;127(8):311-20. Review. German. PMID: 9157537 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.

    Duvic M.

    Clin Lymphoma. 2000 Nov;1 Suppl 1:S51-5. Review.PMID: 11707865 [PubMed - indexed for MEDLINE]Related articles

    8.

    High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.

    Marolleau JP, Baccard M, Flageul B, Rybojad M, Laroche L, Vérola O, Brandely M, Morel P, Gisselbrecht C.

    Arch Dermatol. 1995 May;131(5):574-9.PMID: 7741545 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.

    Kuzel TM, Roenigk HH Jr, Rosen ST.

    J Clin Oncol. 1991 Jul;9(7):1298-313. Review.PMID: 2045869 [PubMed - indexed for MEDLINE]Related articles

    10.

    Management of the primary cutaneous lymphomas.

    Prince HM, McCormack C, Ryan G, O'Keefe R, Seymour JF, Baker C.

    Australas J Dermatol. 2003 Nov;44(4):227-40; quiz 241-2. Review. Erratum in: Australas J Dermatol. 2004 Feb;45(1):82. PMID: 14616487 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cutaneous T-cell lymphoma: a paradigm for biological therapies.

    Pichardo DA, Querfeld C, Guitart J, Kuzel TM, Rosen ST.

    Leuk Lymphoma. 2004 Sep;45(9):1755-65. Review.PMID: 15223633 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.

    Whittaker SJ, Foss FM.

    Cancer Treat Rev. 2007 Apr;33(2):146-60. Epub 2007 Feb 1. Review.PMID: 17275192 [PubMed - indexed for MEDLINE]Related articles

    13.

    Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.

    Duvic M, Chiao N, Talpur R.

    J Cutan Med Surg. 2003 Jul-Aug;7(4 Suppl):3-7. No abstract available. PMID: 12958700 [PubMed - indexed for MEDLINE]Related articles

    14.

    High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.

    Richardson SK, Lin JH, Vittorio CC, Kim EJ, Yoon JS, Junkins-Hopkins J, Rook AH.

    Clin Lymphoma Myeloma. 2006 Nov;7(3):226-32.PMID: 17229339 [PubMed - indexed for MEDLINE]Related articles

    15.

    Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

    Whittaker SJ, Marsden JR, Spittle M, Russell Jones R; British Association of Dermatologists; U.K. Cutaneous Lymphoma Group.

    Br J Dermatol. 2003 Dec;149(6):1095-1107. No abstract available. PMID: 14696593 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interferon in the treatment of cutaneous T-cell lymphoma.

    Olsen EA, Bunn PA.

    Hematol Oncol Clin North Am. 1995 Oct;9(5):1089-107. Review.PMID: 8522486 [PubMed - indexed for MEDLINE]Related articles

    17.

    Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.

    Duvic M.

    Oncology (Williston Park). 2007 Feb;21(2 Suppl 1):33-40. Review.PMID: 17474358 [PubMed - indexed for MEDLINE]Related articles

    18.

    Photopheresis therapy for cutaneous T-cell lymphoma.

    Duvic M, Hester JP, Lemak NA.

    J Am Acad Dermatol. 1996 Oct;35(4):573-9.PMID: 8859287 [PubMed - indexed for MEDLINE]Related articles

    19.

    Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.

    Bunn PA Jr, Ihde DC, Foon KA.

    Int J Cancer Suppl. 1987;1:9-13.PMID: 3305390 [PubMed - indexed for MEDLINE]Related articles

    20.

    Staging and management of cutaneous T-cell lymphoma.

    Scarisbrick JJ.

    Clin Exp Dermatol. 2006 Mar;31(2):181-6. Review.PMID: 16487086 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity